CD276 and bladder transitional cell carcinoma: To investigate correlations between CD276 expression and BLCA patient survival, we first collected 93 tumor tissue specimens from BLCA patients who underwent surgical treatment at the Fourth Medical Center of PLA General Hospital and evaluated CD276 expression using immunohistochemistry (IHC) (Fig. 1a, Supplementary Data 1).